ANI Pharmaceuticals Reports Q2 2026 Financial Results

What Happened

• ANI Pharmaceuticals, Inc. filed a Form 8-K on August 7, 2026 to announce its financial results for the quarter ended June 30, 2026. The company furnished a press release with those results (Exhibit 99.1) and provided an updated investor presentation (Exhibit 99.2) that it may use in investor and analyst meetings.

Key Details

• Filing date: August 7, 2026 (Form 8-K).
• Reporting period: Quarter ended June 30, 2026.
• Exhibits furnished: Press Release (Exhibit 99.1, dated August 7, 2026) and Investor Presentation (Exhibit 99.2, dated August 2026).
• Items reported: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Why It Matters

• This 8-K supplies the company’s latest quarterly results and the presentation management will use when communicating with investors — important sources for earnings, revenue and other quarterly results data.
• Investors should review the press release and investor presentation (available on the SEC EDGAR filing or the company’s investor site) to see the reported figures and any commentary on performance or trends before making investment decisions.